Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology.
about
Prognostic significance of volume-based PET parameters in cancer patients.State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETIntroduction to the analysis of PET data in oncology.Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures.Insight on automated lesion delineation methods for PET data.Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.Semi-automatic analysis of standard uptake values in serial PET/CT studies in patients with lung cancer and lymphoma.FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.Measurement of metabolic tumor volume: static versus dynamic FDG scansMultimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma.Optimising delineation accuracy of tumours in PET for radiotherapy planning using blind deconvolution.Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.Effectiveness of FDG-PET/CT for evaluating early response to induction chemotherapy in head and neck squamous cell carcinoma: A systematic review.Computerized PET/CT image analysis in the evaluation of tumour response to therapy.Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology.Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.Tumor quantification in clinical positron emission tomography.EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.Effects of reusing baseline volumes of interest by applying (non-)rigid image registration on positron emission tomography response assessments.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapyFunctional imaging for radiotherapy treatment planning: current status and future directions-a review.On the Reliability of Automatic Volume Delineation in Low-Contrast [(18)F]FMISO-PET Imaging.A novel phantom technique for evaluating the performance of PET auto-segmentation methods in delineating heterogeneous and irregular lesions.The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction.FDG-PET in Follicular Lymphoma ManagementImpact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method.Assessing margin expansions of internal target volumes in 3D and 4D PET: a phantom study.18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer RadiotherapyA multifractal approach to space-filling recovery for PET quantification.Accurate PET/MR quantification using time of flight MLAA image reconstruction.FDG PET/CT for rectal carcinoma radiotherapy treatment planning: comparison of functional volume delineation algorithms and clinical challenges.PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.Comparative assessment of segmentation algorithms for tumor delineation on a test-retest [(11)C]choline dataset.FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.Optimisation and harmonisation: two sides of the same coin?Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients.
P2860
Q27687836-AAA17EC3-3EBF-4852-B82F-55E663AA22AEQ27694674-763C9F4D-C704-421A-815A-9364791C7F12Q30594766-CE7D637A-218F-4A59-96D6-4A5F78BD09B2Q30645097-C9417C09-9D11-4D9B-A03A-A580F1E6DCB5Q30884650-88D02226-4E6F-4CB1-BCCC-689BEEF95765Q33854382-2F509A02-744A-44BF-A3D0-A9BEB8D93844Q34218478-80B428C0-B723-47AD-94B1-4ACCFC1A2613Q35043725-8AA2386B-1B63-42D3-AB17-8AB4B6AB5AAFQ35593955-4E1B811A-C3A7-4ABC-960F-6F055A0859D5Q35774813-775430EB-4019-4D75-8327-878DFD1056CDQ35830998-FAD5AF4F-FD1C-4623-B6C3-FA05C1F19493Q35849051-33461703-A764-4BEC-ADB3-7032E3683737Q36022493-E60C89C1-E3ED-48DA-9A9A-5ECF1422D454Q36100983-EB54C09A-08B3-46E3-9E90-A34AA5E45ACFQ36295403-112F5219-135F-4476-A17E-EF530406FDB5Q36412502-87FAADD8-2A3E-49D7-A7DD-117948751580Q37042526-83847088-CF57-45D8-A4D7-30BA1E28EDB6Q37342658-5ADE98E9-D39F-4BD2-9FF8-CF49480DABEFQ37433290-C29E821A-4240-4CEA-821B-203DECCCFD60Q37525550-1A73DF73-474E-44BF-8DE6-ABEC2EB56DC3Q38051641-6C2CA87D-0C9E-44BC-8140-16758514B3DDQ38134094-FF84DC73-A7B7-462F-932F-64EDD3B8CC51Q38243086-1E010230-94EB-43BD-841C-907FF962E640Q38397651-1B4E10FA-31E1-4C44-85EE-6FF3851AB72EQ38869444-D09AB3ED-58CC-4E10-9927-EEF9D7FE3D48Q38949870-46E980CF-88E8-4909-9775-386E8DB20984Q40392850-9312C969-C320-4946-B9B3-86449F4A0140Q41840128-6B53EC90-72BD-46B7-8753-E8EE04B94851Q42097286-2A2298E7-7EE3-4858-8CA0-47E6EC10C396Q45353843-6F2628C4-DB91-473E-9D0A-A38540CC068CQ46539805-CA522544-F447-48EE-A8F5-9C1B8163B788Q47418845-3675770A-FF09-4A8D-AA01-1677A1A5A305Q48813461-65225C5C-923D-45CF-B012-C84826BEDAEDQ48896101-3C9FEDE8-9C88-40D1-8CA6-788916BFA421Q51040212-631A7128-7849-44CB-B1F2-703BB8200902Q51223903-8AE2F78A-CC7C-4765-8405-D85B1F9E719CQ51289033-599F9F13-78DD-46BD-818E-D7FB84E25795Q52982144-4714B18C-9A35-4C6D-9C84-D5AD8114DDE4Q53109430-CC79CD3E-D5AE-4BFE-B22D-7FB3D230AA6FQ53120502-CB03EAE9-B2B9-4C66-B312-E6D3ADF1572C
P2860
Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@ast
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@en
type
label
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@ast
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@en
prefLabel
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@ast
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@en
P2093
P2860
P1476
Impact of [¹⁸F]FDG PET imaging ...... umour delineation methodology.
@en
P2093
Floris H P van Velden
Maqsood Yaqub
Otto S Hoekstra
Patsuree Cheebsumon
P2860
P2888
P304
P356
10.1007/S00259-011-1899-5
P577
2011-08-20T00:00:00Z